Home » Topics » Conferences

Conferences
RSS

Potent, orally active, second-generation neuroimmunophilin from Guilford

Sep. 7, 1998

Candidate oral fibrinogen receptor antagonist presented by Uriach at ACS meeting

Sep. 7, 1998

Isoxazoline- and isoxazole-containing factor Xa inhibitors prepared by DuPont

Sep. 7, 1998

LLPGE1 evaluated in pilot study; findings will be applied to future studies

Sep. 4, 1998

Alprostadil alfadex is a promising treatment for ED

Sep. 4, 1998

DW-2282: active enantiomer of DW-2143 and potent antitumor agent

Sep. 4, 1998

Merck KGaA synthesizes new PDE V inhibitor with potential for treating ED

Sep. 4, 1998

Potent mixed delta/mu-opioid agonist identified by Glaxo Wellcome/Delta team

Sep. 4, 1998

Taisho discovers potent and selective CRF1 receptor antagonists with anxiolytic effects

Sep. 4, 1998

Omapatrilat effective therapy for patients with chronic heart failure

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...